(1) Objective: To review the criteria proposed by Cerero-Lapiedra et al. and to retrospectively identify the under-diagnosed disease in patients diagnosed with proliferative verrucous leukoplakia. (2) Materials and methods: In this study, we included patients who were diagnosed with leukoplakia (histological label consistent with the clinical diagnosis, = 95), and cases with a final diagnosis within the spectrum of proliferative verrucous leukoplakia ( = 110) as defined by Batsakis et al.
View Article and Find Full Text PDF© LitMetric 2025. All rights reserved.